Bone pain
Also known as: Pain, Ache, Hurt, Cramp
Methodology & AI Transparency ⓘ
Bone pain Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code M89.8X9 in Arthritis & Joints, Bone pain (also termed Pain or Ache) requires urate-lowering titration [Bone pain M89.8X9] so specialists can calibrate treatment intensity against Weight-Bearing Joint Radiograph [Bone pain M89.8X9] benchmarks.
- 2 Real-world patient consensus: Clinical coding for Bone pain uses ICD-10 M89.8X9 across Arthritis & Joints specialty care.
- 3 Typical cash cost range: Workup highlights for Bone pain (M89.8X9): urate-lowering titration [Bone pain M89.8X9].
- 4 Top reported side effects / signs: Follow-up benchmark in Bone pain: maintaining Weight-Bearing Joint Radiograph [Bone pain M89.8X9] within Preserved joint-space width (M89.8X9).
Ask our AI Specialists anything about Bone pain
What Is Bone pain?
Cataloged under federal diagnostic code M89.8X9 in Arthritis & Joints, Bone pain (also termed Pain or Ache) requires urate-lowering titration [Bone pain M89.8X9] so specialists can calibrate treatment intensity against Weight-Bearing Joint Radiograph [Bone pain M89.8X9] benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Bone pain (code M89.8X9) is monosodium urate or in Bone pain (M89.8X9: calcium pyrophosphate crystal), which Osteoarthritis, Gout & Joint Pain clinicians address while surveilling Weight-Bearing Joint Radiograph [Bone pain M89.8X9] (Preserved joint-space width (M89.8X9)).
Common Symptoms & Clinical Signs
- • Presentation of Bone pain (M89.8X9): localized tendon or in Bone pain (M89.8X9: bursa tenderness limiting)
- • Secondary Bone pain clinical sign: activity-related deep aching in Bone pain (M89.8X9: joint pain in)
- • Symptom flares in Bone pain correlating with Weight-Bearing Joint Radiograph [Bone pain M89.8X9] deviation outside Preserved joint-space width (M89.8X9)
- • Functional arthritis & joints impact requiring urate-lowering titration [Bone pain M89.8X9] evaluation (M89.8X9)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Bone pain Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M89.8X9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoarthritis, Gout & Joint Pain | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Weight-Bearing Joint Radiograph [Bone pain M89.8X9] | Preserved joint-space width (M89.8X9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Uric Acid in Bone pain (M89.8X9: (Gout Target)) | < 6.0 mg/dL (< 5.0 mg/dL with tophi) (M89.8X9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: hs-CRP & Erythrocyte in Bone pain (M89.8X9: Sedimentation Rate) | hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M89.8X9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Bone pain
Treatment selection for Bone pain depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Bone pain)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Testosterone supplementation and bone: What a 3,103-Participant Study Found TRT is able to inhibit bone resorption and increase bone mass, particularly at the lumbar spine level and when the duration is long enough to allow the anabolic effect of T and estrogens on bone metabolism to take place. Journal of endocrinological investigation • 2022-05-15 • Meta-Analysis | N = 3,103 | 99/100 | PMID 35041193 ↗ |
| New Insights on Different Anti-Hyperglycaemic Treatments on Bone Turnover Markers and Bone: What a 4,914-Participant Study Found High heterogeneity and diverse follow-up durations among studies were evident, which obscures the validity of the results. International journal of molecular sciences • 2024-07-22 • Meta-Analysis | N = 4,914 | 99/100 | PMID 39063229 ↗ |
| New Insights on Contrasting Bone Profiles in PCOS Are Related to: What a 1,822-Participant Study Found The findings of this study alert for a low bone mass, low bone formation, and increased bone resorption PCOS with a BMI <27 kg/m2. The Journal of clinical endocrinology and metabolism • 2024-09-16 • Meta-Analysis | N = 1,822 | 94/100 | PMID 38739756 ↗ |
| New Insights on Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A: What a 447-Participant Study Found We did not find sufficient evidence to suggest any detrimental effect of pelvic XRT on the treatment effect from denosumab on percent BMD change, with only an approximately 5% incidence of clinical fractures. International journal of radiation oncology, biology, physics • 2024-05-01 • Phase III Randomized Trial | N = 447 | 93/100 | PMID 37924987 ↗ |
| New Insights on Benefits and safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients: What a 357-Participant Study Found Denosumab biosimilar QL1206 had promising efficacy, tolerable safety, and how the body absorbs the medicine equivalent to denosumab and could benefit patients with bone metastases from solid tumors. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy • 2023-03-15 • Phase III Randomized Trial | N = 357 | 93/100 | PMID 36802320 ↗ |
Bone pain Patient Community & “People Like Me” Threads
Filter Bone pain community threads and patient logs by age, biological sex, dosage, and treatment duration.